Filter
204
Filtered Results: 204
Text search:
Dr.
Y.
Pillay
Featured
Recommendations
21
New Publications
60
Language
Document type
No document type
101
Studies & Reports
46
Guidelines
28
Strategic & Response Plan
13
Manuals
11
Situation Updates
3
Fact sheets
2
Countries / Regions
South Africa
16
Congo, Democratic Republic of
14
Kenya
12
Sierra Leone
9
India
6
Malawi
5
Latin America and the Carribbean
5
Western and Central Europe
5
East and Southern Africa
5
Lesotho
4
Africa
4
Asia
4
Zambia
4
Indonesia
4
Laos
3
Zimbabwe
3
Philippines
3
Global
3
West and Central Africa
3
Eastern Europe
3
Brazil
3
Central African Republic
3
Liberia
3
Nepal
2
Timor Leste/ East Timor
2
Thailand
2
Syria
2
Nigeria
2
Senegal
2
Venezuela
2
Bangladesh
2
Ethiopia
2
Myanmar / Burma
2
North Korea
1
Ghana
1
Rwanda
1
Burkina Faso
1
Peru
1
Guinea
1
Mozambique
1
Cambodia
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Mauritius
1
Southern Africa
1
Vietnam
1
Uganda
1
Sri Lanka
1
Namibia
1
Bhutan
1
Botswana
1
South Sudan
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
105
Clinical Guidelines
21
Key Resources
11
Public Health
10
Women & Child Health
8
Pharmacy & Technologies
3
Capacity Building
1
Toolboxes
TB
19
HIV
18
COVID-19
14
Mental Health
12
NTDs
6
Rapid Response
5
Caregiver
5
Global Health Education
5
Ebola & Marburg
4
Pharmacy
4
NCDs
4
Conflict
4
AMR
4
Specific Hazards
2
Zika
2
Natural Hazards
1
Disability
1
Cholera
1
Planetary Health
1
Guidelines for Management and Treatment of Dyslipidemia in Indonesia
Shoman et al. Globalization and Health (2017) 13:1 DOI 10.1186/s12992-016-0224-2
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248
In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientific knowledge pe...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
As of 6:00 PM, 21 November 2013, 4,011 individuals were reported dead, 18,567 injured and 1,602 are still missing
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
Q12. SCOPING QUESTION: In people with psychotic disorders, including schizophrenia and bipolar disorder, are recovery-oriented strategies enhancing vocational and economic inclusion (such as supported employment) feasible and effective?
Johnson CC et al. Journal of the International AIDS Society 2017, 20:21594 http://www.jiasociety.org/index.php/jias/article/view/21594 | https://doi.org/10.7448/IAS.20.1.21594
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
AIDS Research and Therapy 2015, 12:12 (24 April 2015)
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation of yaws eradication activities and WHO technical staff who provide te...
